Back
Nuveen AMT-Free Municipal Credit Income Fund Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
46
NVG
Nuveen AMT-Free Municipal Credit Income Fund
Last Price:
13.23
Seasonality Move:
2%
Sell
25
DRUG
Bright Minds Biosciences
Last Price:
43.34
Seasonality Move:
-15.89%
Sell
46
Nuveen AMT-Free Municipal Credit Income Fund (NVG)
is a Sell
Is Nuveen AMT-Free Municipal Credit Income Fund a Buy, Sell or Hold?
- The current Nuveen AMT-Free Municipal Credit Income Fund [NVG] share price is $13.13. The Score for NVG is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- NVG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG] share price is $39.18. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVG Stock Price Chart
What is Nuveen AMT-Free Municipal Credit Income Fund's stock price today?
-
The Nuveen AMT-Free Municipal Credit Income Fund share price today is $13.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVG is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $39.18
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.
NVG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 59.46 | Buy |
Chaikin Money Flow: | 370142 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.6 - 12.94) | Buy |
Bollinger Bands (100): | (12.58 - 13.26) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.15 | Buy |
Relative Strength Index (14 RSI): | 52.97 | Buy |
Chaikin Money Flow: | -1839 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.22 - 49.76) | Sell |
Bollinger Bands (100): | (-5.38 - 34.26) | Buy |
NVG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.89 | Buy |
20-day SMA: | 12.8 | Buy |
50-day SMA: | 13.04 | Buy |
200-day SMA: | 12.44 | Buy |
8-day EMA: | 12.93 | Buy |
20-day EMA: | 12.88 | Buy |
50-day EMA: | 12.92 | Buy |
200-day EMA: | 12.53 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.22 | Buy |
20-day SMA: | 42.44 | Sell |
50-day SMA: | 27.75 | Buy |
200-day SMA: | 7.85 | Buy |
8-day EMA: | 37.92 | Buy |
20-day EMA: | 38.62 | Buy |
50-day EMA: | 30.54 | Buy |
200-day EMA: | 12.66 | Buy |
Nuveen AMT-Free Municipal Credit Income Fund Earnings Growth & NVG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nuveen AMT-Free Municipal Credit Income Fund Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |